D
LENSAR, Inc. LNSR
$13.91 $0.020.14% NASDAQ
Recommendation
Prev Close
$13.89
Volume
170,669
Avg Vol (90D)
139,665
Market Cap
$163.76M
Dividend & Yield
--
52-Week Range
$2.95 - $17.31
P/E (TTM)
--
EPS (TTM)
-$2.72
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
LENSAR, Inc. (NASDAQ:LNSR) Sees Significant Decrease in Short Interest
4/22/2025 - Ticker Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, TURN, DNB, GB on Behalf of Shareholders
4/21/2025 - Globe Newswire
LENSAR, Inc. (NASDAQ:LNSR) Short Interest Update
4/21/2025 - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, TURN, DNB, GB on Behalf of Shareholders
4/17/2025 - PR Newswire
Is LENSAR (LNSR) a Deeply Undervalued Stock?
4/10/2025 - Insider Monkey
Is LENSAR (LNSR) a Deeply Undervalued Stock?
4/10/2025 - Yahoo! Finance: News
ALC Stock May Rise With the Introduction of PanOptix Pro in US
4/3/2025 - Zacks Investment Research
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AZEK, LNSR, DNB on Behalf of Shareholders
3/28/2025 - PR Newswire
Alcon (ALC) Soars 6.0%: Is Further Upside Left in the Stock?
3/28/2025 - Zacks Investment Research
Alcon to buy Lensar in deal worth up to $430M
3/27/2025 - Bizjournals.com - Health Care News
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC ...
3/26/2025 - GuruFocus
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR
3/26/2025 - Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AZEK, LNSR, DNB on Behalf of Shareholders
3/26/2025 - Globe Newswire
Lake Street Capital Reaffirms "Hold" Rating for LENSAR (NASDAQ:LNSR)
3/25/2025 - MarketBeat
Alcon signs merger agreement to acquire Lensar
3/25/2025 - Yahoo! Finance: News
Alcon Stock Might Rise as Clareon Vivity IOL Secures CE Mark Approval
3/25/2025 - Zacks Investment Research
ALC Stock Rises Following the Merger Agreement With LENSAR
3/25/2025 - Zacks Investment Research
Lensar just downgraded at BTIG, here's why
3/24/2025 - The Fly
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AZEK, LNSR, DNB on Behalf of Shareholders
3/24/2025 - PR Newswire
Lensar just downgraded at Lake Street, here's why
3/24/2025 - The Fly
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of LENSAR, Inc. - LNSR
3/24/2025 - GuruFocus
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of LENSAR, Inc. - LNSR
3/24/2025 - PR Newswire
Alcon Eyes Surgical Edge With LENSAR Buyout: Details
3/24/2025 - Benzinga
LNSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LENSAR, Inc. ...
3/24/2025 - GuruFocus
Shareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. ...
3/24/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$53.49M
EBITDA (TTM)
-$4.37M
EBIT (TTM)
-$8.30M
Net Income (TTM)
-$31.40M
Balance Sheet
Total Assets (Q)
$66.30M
Total Debt (Q)
$2.61M
Total Liabilities (Q)
$47.65M
Book Value Per Share (Q)
$0.4172
Cash Flow
Cash from Operations (TTM)
-$2.28M
Cash from Investing (TTM)
-$2.16M
Cash from Financing (TTM)
$78.00K
Net Change in Cash (TTM)
-$4.36M
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.03
7-Day Total Return
3.04%
30-Day Total Return
-4.73%
60-Day Total Return
25.48%
90-Day Total Return
80.42%
Year to Date Total Return
60.07%
1-Year Total Return
305.54%
2-Year Total Return
435.00%
3-Year Total Return
82.31%
5-Year Total Return
--
52-week Low
May 01, 2024 - $2.95
52-week High
Mar 19, 2025 - $17.31
Valuation
Market Cap
$163.76M - Micro Cap
Enterprise Value
$157.70M
Price/Sales (TTM)
3.02
Price/Book (Q)
33.29
Dividends and Shares
Shares Outstanding
11.63M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.lensar.com
Phone Number
888 536 7271
Address
2800 Discovery Drive
Orlando, FL 32826
Country
United States
Year Founded
2004
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or... more
NASDAQ 04/25/2025 4:00PM Eastern Quotes delayed